Indications & Dosage

Indications:

The management of bronchospasm in patients suffering from chronic obstructive pulmonary disease who require regular
treatment with both ipratropium and salbutamol.

Dosage and Administration
Salbutamol + Ipratropium are intended for inhalation only and may be administered from a suitable nebuliser or an
intermittent positive pressure ventilator.

Treatment should be initiated and administered under medical supervision, e.g. in the hospital setting. Home based treatment can be recommended in exceptional cases (severe symptoms or experienced patients requiring higher doses) when a low dose rapid acting beta-agonist bronchodilator has been insufficient in providing relief after consultation with an experienced physician.

The treatment with the nebuliser solution in UDVs should always be started with the lowest recommended dose (1 UDV). In very severe cases two unit dose vials may be required for symptom relief. Administration should be stopped when sufficient symptom relief is achieved.

The recommended dose is:
Adults (including elderly patients and children over 12 years):
1 single dose unit three or four times daily.

Children under 12 years:
There is no experience of the use of Salbutamol + Ipratropium in children under 12 years.

Or as prescribed by the physician.